Page last updated: 2024-09-03

san 202791 and oxadiazoles

san 202791 has been researched along with oxadiazoles in 2 studies

Compound Research Comparison

Studies
(san 202791)
Trials
(san 202791)
Recent Studies (post-2010)
(san 202791)
Studies
(oxadiazoles)
Trials
(oxadiazoles)
Recent Studies (post-2010) (oxadiazoles)
31026,0572572,359

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artalejo, CR; Fonteriz, RI; Gandia, L; GarcĂ­a, AG; Lopez, MG1
Kan, E; Kelly, JE; Lokuta, AJ; Nishio, M; Sagawa, K; Sagawa, T; Tsai, J; Wasserstrom, JA1

Other Studies

2 other study(ies) available for san 202791 and oxadiazoles

ArticleYear
Dihydropyridine chirality at the chromaffin cell calcium channel.
    Brain research, 1987, Apr-07, Volume: 408, Issue:1-2

    Topics: Adrenal Medulla; Animals; Calcium; Catecholamines; Cats; Chromaffin System; Dihydropyridines; Female; Ion Channels; Isradipine; Male; Oxadiazoles; Potassium; Pyridines; Stereoisomerism

1987
Activation of purified cardiac ryanodine receptors by dihydropyridine agonists.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Dogs; Membrane Potentials; Myocardium; Nicotinic Acids; Nifedipine; Oxadiazoles; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Stereoisomerism

2001